Login / Signup

Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy.

Tara M DavidsonNathan FosterFabrice LucienSvetomir MarkovicHaidong DongJeffrey L WintersSean S ParkJacob J Orme
Published in: BMJ open (2022)
NCT04581382.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • study protocol
  • clinical trial
  • papillary thyroid
  • randomized controlled trial
  • squamous cell
  • phase ii study
  • squamous cell carcinoma